In the present study, we identified SBSPON as a novel HSPA5 binding glycoprotein and tumor suppressor, and investigated the molecular mechanism of its cellular function and regulatory roles in bladder cancer progression and cisplatin resistance. Here, SBSPON is linked to urinary bladder carcinoma.